284 related articles for article (PubMed ID: 35573683)
1. Long Non-Coding RNAs as Molecular Biomarkers in Cholangiocarcinoma.
Wu Y; Hayat K; Hu Y; Yang J
Front Cell Dev Biol; 2022; 10():890605. PubMed ID: 35573683
[TBL] [Abstract][Full Text] [Related]
2. Functions and roles of long noncoding RNA in cholangiocarcinoma.
Li J; Huang L; Li Z; Zhong X; Tai S; Jiang X; Cui Y
J Cell Physiol; 2019 Aug; 234(10):17113-17126. PubMed ID: 30888066
[TBL] [Abstract][Full Text] [Related]
3. miRNA and lncRNA as biomarkers in cholangiocarcinoma(CCA).
Zheng B; Jeong S; Zhu Y; Chen L; Xia Q
Oncotarget; 2017 Nov; 8(59):100819-100830. PubMed ID: 29246025
[TBL] [Abstract][Full Text] [Related]
4. LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner.
Wang WT; Ye H; Wei PP; Han BW; He B; Chen ZH; Chen YQ
J Hematol Oncol; 2016 Nov; 9(1):117. PubMed ID: 27809873
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition.
Xu Y; Yao Y; Qin W; Zhong X; Jiang X; Cui Y
Biomed Pharmacother; 2018 Mar; 99():121-127. PubMed ID: 29329034
[TBL] [Abstract][Full Text] [Related]
6. Emerging roles of long noncoding RNAs in cholangiocarcinoma: Advances and challenges.
Yang Y; Deng X; Li Q; Wang F; Miao L; Jiang Q
Cancer Commun (Lond); 2020 Dec; 40(12):655-680. PubMed ID: 33142045
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma.
Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Gao J; Cui Y; Zhong X
Sci Rep; 2018 Aug; 8(1):12176. PubMed ID: 30111807
[TBL] [Abstract][Full Text] [Related]
8. SOX2 knockdown slows cholangiocarcinoma progression through inhibition of transcriptional activation of lncRNA PVT1.
Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H
Biochem J; 2020 Sep; 477(18):3527-3540. PubMed ID: 32812642
[TBL] [Abstract][Full Text] [Related]
9. The Advancement of Long Non-Coding RNAs in Cholangiocarcinoma Development.
Jiang F; Ling X
J Cancer; 2019; 10(11):2407-2414. PubMed ID: 31258745
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide identification of a competing endogenous RNA network in cholangiocarcinoma.
Li G; Liu T; Zhang B; Chen W; Ding Z
J Cell Biochem; 2019 Nov; 120(11):18995-19003. PubMed ID: 31270845
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA LINC00665 promotes gemcitabine resistance of Cholangiocarcinoma cells via regulating EMT and stemness properties through miR-424-5p/BCL9L axis.
Lu M; Qin X; Zhou Y; Li G; Liu Z; Geng X; Yue H
Cell Death Dis; 2021 Jan; 12(1):72. PubMed ID: 33436545
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of lncRNA TP73-AS1 predicts adverse phenotypes for cholangiocarcinoma and exerts oncogenic properties in vitro and in vivo.
Yao Y; Sun Y; Jiang Y; Qu L; Xu Y
Biomed Pharmacother; 2018 Oct; 106():260-266. PubMed ID: 29966969
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of long noncoding RNA H19 indicates a poor prognosis for cholangiocarcinoma and promotes cell migration and invasion by affecting epithelial-mesenchymal transition.
Xu Y; Wang Z; Jiang X; Cui Y
Biomed Pharmacother; 2017 Aug; 92():17-23. PubMed ID: 28528181
[TBL] [Abstract][Full Text] [Related]
14. The prognostic potential and carcinogenesis of long non-coding RNA TUG1 in human cholangiocarcinoma.
Xu Y; Leng K; Li Z; Zhang F; Zhong X; Kang P; Jiang X; Cui Y
Oncotarget; 2017 Sep; 8(39):65823-65835. PubMed ID: 29029475
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA LOXL1-AS1 acts as a ceRNA for miR-324-3p to contribute to cholangiocarcinoma progression via modulation of ATP-binding cassette transporter A1.
Zhang B; Zhou M; Zou L; Miao J; Wang Y; Li Y; Lu S; Yu J
Biochem Biophys Res Commun; 2019 Jun; 513(4):827-833. PubMed ID: 31003776
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of long noncoding RNA-associated competing endogenous RNA network in cholangiocarcinoma.
Song W; Miao DL; Chen L
Biochem Biophys Res Commun; 2018 Dec; 506(4):1004-1012. PubMed ID: 30404735
[TBL] [Abstract][Full Text] [Related]
17. lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma.
Qiu G; Ma D; Li F; Sun D; Zeng Z
Int J Oncol; 2019 Jul; 55(1):45-58. PubMed ID: 31059014
[TBL] [Abstract][Full Text] [Related]
18. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA myocardial infarction associated transcript promotes the proliferation of cholangiocarcinoma cells by targeting miR-551b-3p/CCND1 axis.
Chang W; Wang Y; Li W; Geng Z
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1067-1075. PubMed ID: 32064660
[TBL] [Abstract][Full Text] [Related]
20. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
